|
1. |
Baumgartner H, Bonhoeffer P, De Groot NM et al. Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC); Association for European Paediatric Cardiology (AEPC); ESC Committee for Practice Guidelines (CPG). ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J. 2010 Dec;31(23):2915-57. doi: 10.1093/eurheartj/ehq249. Epub 2010 Aug 27. PMID: 20801927.
| |
|
2. |
Sakai LY, Keene DR, Renard M, De Backer J (2016) FBN1: The disease-causing gene for Marfan syndrome and other genetic disorders. Gene 591:279–291. https://doi.org/10.1016/j.gene.2016.07.033
| |
|
3. |
Guo D, Tan FK, Cantu A, Plon SE, Milewicz DM (2001) FBN1 exon 2 splicing error in a patient with Marfan syndrome. Am J Med Genet 101:130–134. https://doi.org/10.1002/1096-8628(20010615)101:2%3c130::aid-ajmg1333%3e3.0.co;2-v
| |
|
4. |
Takeda N, Inuzuka R, Maemura S et al. Impact of pathogenic FBN1 variant types on the progression of aortic disease in patients with Marfan syndrome. Circ Genomic Precis Med. 2018;11(6):e002058. doi: 10.1161/CIRCGEN.117.002058.
| |
|
5. |
Franken R, Heesterbeek TJ, De Waard V et al. Diagnosis and genetics of Marfan syndrome. Expert Opin Orphan Drugs. 2014;2(10):1049–1062. doi: 10.1517/21678707.2014.950223.
| |
|
6. |
Robertson I, Jensen S, Handford P. TB domain proteins: evolutionary insights into the multifaceted roles of fibrillins and LTBPs. Biochem J. 2011;433(2):263–276. doi: 10.1042/BJ20101320.
| |
|
7. |
Benke K, Ágg B, Szilveszter B et al. The role of transforming growth factor-beta in Marfan syndrome. Cardiol J. 2013;20(3):227–234. doi: 10.5603/CJ.2013.0066.
| |
|
8. |
Stengl R, Ágg B, Pólos M, Mátyás G, Szabó G et al (2021) Potential predictors of severe cardiovascular involvement in Marfan syndrome: the emphasized role of genotype-phenotype correlations in improving risk stratification-a literature review. Orphanet J Rare Dis 16:245. https://doi.org/10.1186/s13023-021-01882-6
| |
|
9. |
Baudhuin LM, Kotzer KE, Lagerstedt SA. Increased frequency of FBN1 truncating and splicing variants in Marfan syndrome patients with aortic events. Genet Med. 2015 Mar;17(3):177-87. doi: 10.1038/gim.2014.91. Epub 2014 Aug 7. PMID: 25101912.
| |
|
10. |
Tiecke, F., Katzke, S., Booms, P. et al. Classic, atypically severe and neonatal Marfan syndrome: twelve mutations and genotype–phenotype correlations in FBN1 exons 24–40. Eur J Hum Genet 9, 13–21 (2001). https://doi.org/10.1038/sj.ejhg.5200582
| |
|
11. |
Hutchinson S, Furger A, Halliday D et al. Allelic variation in normal human FBN1 expression in a family with Marfan syndrome: a potential modifier of phenotype? Hum Mol Genet. 2003;12:2269–2276. doi: 10.1093/hmg/ddg241.;
| |
|
12. |
AubartM, Gross MS, Hanna N et al. The clinical presentation of Marfan syndrome is modulated by expression of wild-type FBN1 allele. Hum Mol Genet. 2015 May 15;24(10):2764-70. doi: 10.1093/hmg/ddv037. Epub 2015 Feb 4. PMID: 25652400.
| |
|
13. |
Judge D.P., Dietz H.C. Marfan’s syndrome. Lancet. 2005;366:1965–1976. doi: 10.1016/S0140-6736(05)67789-6.
| |
|
14. |
Dietz H. Marfan Syndrome. 2001 Apr 18 [Updated 2017 Oct 12]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2021.
| |
|
15. |
Wozniak-Mielczarek L., Sabiniewicz R., Drezek-Nojowicz M. et al. Differences in Cardiovascular Manifestation of Marfan Syndrome Between Children and Adults. Pediatric Cardiol. 2019;40:393–403. doi: 10.1007/s00246-018-2025-2
| |
|
16. |
Adams J.N., Trent R.J. Aortic complications of Marfan’s syndrome. Lancet. 1998;352:1722–1723. doi: 10.1016/S0140-6736(05)79822-6.
| |
|
17. |
Loeys BL, Dietz HC, Braverman AC et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010 Jul;47(7):476-85. doi: 10.1136/jmg.2009.072785. PMID: 20591885.
| |
|
18. |
Stark VC, Arndt F, Harring G, von Kodolitsch Y, Kozlik-Feldmann R, Mueller GC, Steiner KJ, Mir TS. Kid-Short Marfan Score (Kid-SMS) Is a Useful Diagnostic Tool for Stratifying the Pre-Test Probability of Marfan Syndrome in Childhood. Diseases. 2015 Mar 12;3(1):24-33. doi: 10.3390/diseases3010024. PMID: 28943606; PMCID: PMC5548230.
| |
|
19. |
Хасанова, C. И., Парфенова, Н. Н., Митрофанова, Л. Б., & Земцовский, Э. В. (2011). Марфаноидная внешность как предиктор развития кальцифицирующего стеноза аортального клапана. Сибирский журнал клинической и экспериментальной медицины, 26 (3-2), 31-34.
| |
|
20. |
Тимофеев Е. В., Малев Э. Г., Парфенова Н. Н. и соавт. Расширение грудного отдела аорты и активность трансформирующего фактора роста-β у пациентов с марфаноидной внешностью. Медицина: теория и практика, vol. 4, no. 3, 2019, pp. 142-147.
| |
|
21. |
Тимофеев Е.В., Реева С.В., Лобанов М.Ю.,Земцовский Э.В. Марфаноидная внешность как предиктор нарушений сердечного ритма у лиц различных возрастных групп DOI: https://dx.doi.org/10.18565/therapy.2018.6.84-90
| |
|
22. |
Lewandowska-Walter A, Trawicka A, Bogdanowicz M, et al. Families of people with Marfan syndrome. The relationship between the functioning of the family system and the life quality of the affected persons. Psychiatr Pol. 2021 Aug 31;55(4):815-834. English, Polish. doi: 10.12740/PP/OnlineFirst/114838. Epub 2021 Aug 31. PMID: 34994739.
| |
|
23. |
Beighton P, de Paepe A, Danks D, et al. International Nosology of Heritable Disorders of Connective Tissue, Berlin, 1986. Am J Med Genet. 1988 Mar;29(3):581-94. doi: 10.1002/ajmg.1320290316. PMID: 3287925.
| |
|
24. |
Beighton P, De Paepe A, Steinmann B, et al. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet. 1998 Apr 28;77(1):31-7. PMID: 9557891.
| |
|
25. |
Malfait F, Francomano C, Byers P, et al. The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):8-26. doi: 10.1002/ajmg.c.31552. PMID: 28306229.
| |
|
26. |
Jørgensen A, Fagerheim T, Rand-Hendriksen S, et al. Vascular Ehlers-Danlos Syndrome in siblings with biallelic COL3A1 sequence variants and marked clinical variability in the extended family. Eur J Hum Genet. 2015 Jun;23(6):796-802. doi: 10.1038/ejhg.2014.181. Epub 2014 Sep 10. PMID: 25205403; PMCID: PMC4795069.
| |
|
27. |
Frank M, Albuisson J, Ranque B, et al. The type of variants at the COL3A1 gene associates with the phenotype and severity of vascular Ehlers-Danlos syndrome. Eur J Hum Genet. 2015 Dec;23(12):1657-64. doi: 10.1038/ejhg.2015.32. Epub 2015 Mar 11. PMID: 25758994; PMCID: PMC4795191.
| |
|
28. |
Malfait F, Castori M, Francomano CA, et al. The Ehlers-Danlos syndromes. Nat Rev Dis Primers. 2020 Jul 30;6(1):64. doi: 10.1038/s41572-020-0194-9. PMID: 32732924.
| |
|
29. |
Byard RW (2017) Manifestations and Medicolegal Significance of Loeys-Dietz Syndrome. J Forensic Sci 62:1512–1515. https://doi.org/10.1111/1556-4029.13466
| |
|
30. |
Mac Carrick G, Black JH 3rd, Bowdin S, et al. Loeys-Dietz syndrome: a primer for diagnosis and management. Genet Med. 2014 Aug;16(8):576-87. doi: 10.1038/gim.2014.11. Epub 2014 Feb 27. PMID: 24577266; PMCID: PMC4131122.
| |
|
31. |
Meester J, Verstraeten A, Schepers D, et al. Differences in manifestations of Marfan syndrome, Ehlers-Danlos syndrome, and Loeys-Dietz syndrome. Ann Cardiothorac Surg. 2017 Nov;6(6):582-594. doi: 10.21037/acs.2017.11.03. PMID: 29270370; PMCID: PMC5721110.
| |
|
32. |
Faggion VT, Zafar MA, Ziganshin BA, Elefteriades JA. Nonsyndromic Thoracic Aortic Aneurysms and Dissections-Is Screening Possible? Semin Thorac Cardiovasc Surg. 2019 Winter;31(4):628-634. doi: 10.1053/j.semtcvs.2019.05.035. Epub 2019 Jun 15. PMID: 31212014.
| |
|
33. |
Callewaert B, De Paepe A, Coucke P. Arterial Tortuosity Syndrome. 2014 Nov 13 [Updated 2023 Feb 23]. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2025.
| |
|
34. |
Broeren E, Gitau V, Byrne A, et al. The ClinGen Syndromic Disorders Gene Curation Expert Panel: Assessing the Clinical Validity of 111 Gene-Disease Relationships. medRxiv [Preprint]. 2024 Nov 20:2024.11.19.24317561. doi: 10.1101/2024.11.19.24317561. PMID: 39606380; PMCID: PMC11601709.
| |
|
35. |
Renard M, Francis C, Ghosh R, et al. Clinical Validity of Genes for Heritable Thoracic Aortic Aneurysm and Dissection. J Am Coll Cardiol. 2018 Aug 7;72(6):605-615. doi: 10.1016/j.jacc.2018.04.089. PMID: 30071989; PMCID: PMC6378369.
| |
|
36. |
Frédéric, M. Y., Lalande, M., Boileau, C., et al. (2009). UMD-predictor, a new prediction tool for nucleotide substitution pathogenicity -- application to four genes: FBN1, FBN2, TGFBR1, and TGFBR2. Human mutation, 30(6), 952–959. https://doi.org/10.1002/humu.20970)
| |
|
37. |
Richards S, Aziz N, Bale S, et al. ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5. PMID: 25741868; PMCID: PMC4544753.)
| |
|
38. |
Isselbacher EM, Preventza O, Hamilton B.J. et al.; Peer Review Committee Members. 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2022 Dec 13;146(24):e334-e482. doi: 10.1161/CIR.0000000000001106. Epub 2022 Nov 2. PMID: 36322642; PMCID: PMC9876736.
| |
|
39. |
Shalhub S, Byers PH, Hicks KL, et al. A multi-institutional experience in vascular Ehlers-Danlos syndrome diagnosis. J Vasc Surg. 2020;71:149–57.
| |
|
40. |
Loeys BL, Dietz HC. Loeys-Dietz Syndrome. 2008 Feb 28 [Updated 2024 Sep 12]. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1133/
| |
|
41. |
Laura Muiño-Mosquera, Elena Cervi, Katya De Groote, et al. Management of aortic disease in children with FBN1-related Marfan syndrome: A joint statement from the paediatric subgroup of the European Reference Network of Vascular Diseases (VASCERN, Heritable Thoracic Aortic Disease working group) and the Association for European Paediatric and Congenital Cardiology (AEPC), European Heart Journal, Volume 45, Issue 39, 14 October 2024, Pages 4156–4169, https://doi.org/10.1093/eurheartj/ehae526
| |
|
42. |
Green RC, Berg JS, Grody WW, et al.; American College of Medical Genetics and Genomics. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 2013 Jul;15(7):565-74. doi: 10.1038/gim.2013.73. Epub 2013 Jun 20. Erratum in: Genet Med. 2017 May;19(5):606. doi: 10.1038/gim.2017.18. PMID: 23788249; PMCID: PMC3727274.
| |
|
43. |
ClinGen FBN1 Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 1 (Интернет-ресурс https://clinicalgenome.org/docs/clingen-fbn1-expert-panel-specifications-to-the-acmg-amp-variant-interpretation-guidelines-version-1/)
| |
|
44. |
Dietz H. FBN1-Related Marfan Syndrome. 2001 Apr 18 [Updated 2022 Feb 17]. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1335/
| |
|
45. |
Nucera M, Heinisch PP, Langhammer B, et al. The impact of sex and gender on aortic events in patients with Marfan syndrome. Eur J Cardiothorac Surg. 2022 Oct 4;62(5):ezac305. doi: 10.1093/ejcts/ezac305. PMID: 35543473.
| |
|
46. |
Y. Seike, H. Matsuda, H. Ishibashi-Ueda, et al. Surgical outcome and histological differences between individuals with TGFBR1 and TGFBR2 mutations in Loeys-Dietz syndrome. Ann. Thoracic Cardiovasc. Surg. (2021), 10.5761/atcs.oa.20-00223 Epub 2021/01/08. (PubMed PMID: 33408307)
| |
|
47. |
Goland S, Elkayam U. Pregnancy and Marfan syndrome. Ann Cardiothorac Surg. 2017 Nov;6(6):642-653. doi: 10.21037/acs.2017.10.07. PMID: 29270376; PMCID: PMC5721114.
| |
|
48. |
Roman MJ, Rosen SE, Kramer-Fox R, Devereux RB. Prognostic significance of the pattern of aortic root dilation in the Marfan syndrome. J Am Coll Cardiol. 1993 Nov 1;22(5):1470-6. doi: 10.1016/0735-1097(93)90559-j. PMID: 8227807.
| |
|
49. |
Girardi LN, Lau C, Gambardella I. Aortic dimensions as predictors of adverse events. J Thorac Cardiovasc Surg. 2021 Apr;161(4):1193-1197. doi: 10.1016/j.jtcvs.2020.06.137. Epub 2020 Jul 16. PMID: 32792149.
| |
|
50. |
Интернет-ресурс «The Marfan Foundation» https://marfan.org/ (Дата обращения: 17.02.2025).
| |
|
51. |
Authors/Task Force Members; Czerny M, Grabenwöger M, Berger T, et al. EACTS/STS Guidelines for Diagnosing and Treating Acute and Chronic Syndromes of the Aortic Organ. Ann Thorac Surg. 2024 Jul;118(1):5-115. doi: 10.1016/j.athoracsur.2024.01.021. Epub 2024 Feb 26. PMID: 38416090.
| |
|
52. |
Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al; ESC Scientific Document Group. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018 Sep 7;39(34):3165-3241. doi: 10.1093/eurheartj/ehy340. PMID: 30165544.
| |
|
53. |
Morris, S. A., Flyer, J. N., Yetman, A. T., et al. & American Heart Association Council on Lifelong Congenital Heart Disease and Heart Health in the Young (Young Hearts); Council on Cardiovascular and Stroke Nursing; Council on Peripheral Vascular Disease; Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; and Council on Cardiovascular Surgery and Anesthesia (2024). Cardiovascular Management of Aortopathy in Children: A Scientific Statement From the American Heart Association. Circulation, 150(11), e228–e254. https://doi.org/10.1161/CIR.0000000000001265
| |
|
54. |
Beighton P, Solomon L, Soskolne CL. Articular mobility in an African population. Ann Rheum Dis. 1973;32(5):413–418. doi: 10.1136/ard.32.5.413.
| |
|
55. |
Strang-Karlsson S, Keigwin S, Anttonen AK, et al. Multi-exon COL5A1 deletion in a child with classical Ehlers-Danlos syndrome: A case report expanding the allelic spectrum and showing evidence of parental gonosomal mosaicism. Clin Case Rep. 2022 Oct 11;10(10):e6455. doi: 10.1002/ccr3.6455. PMID: 36245460; PMCID: PMC9552984
| |
|
56. |
Meester JA, Vandeweyer G, Pintelon I et al (2017) Loss-of-function mutations in the X-linked biglycan gene cause a severe syndromic form of thoracic aortic aneurysms and dissections. Genet Med 19(4):386–395
| |
|
57. |
Verstraeten A, Alaerts M, Van Laer L, Loeys B. Marfan Syndrome and Related Disorders: 25 Years of Gene Discovery. Hum Mutat. 2016 Jun;37(6):524-31. doi: 10.1002/humu.22977. Epub 2016 Mar 14. PMID: 26919284.
| |
|
58. |
Arnaud P, Milleron O, Hanna N, et al. Clinical relevance of genotype-phenotype correlations beyond vascular events in a cohort study of 1500 Marfan syndrome patients with FBN1 pathogenic variants. Genet Med. 2021 Jul;23(7):1296-1304. doi: 10.1038/s41436-021-01132-x. Epub 2021 Mar 17. PMID: 33731877; PMCID: PMC8257477.
| |
|
59. |
Рыжкова О.П.и др. Руководство по интерпретации данных последовательности ДНК человека, полученных методами массового параллельного секвенирования (MPS) (редакция 2018, версия 2). Медицинская генетика. 2019;18(2):3-23.
| |
|
60. |
Byers PH, Belmont J, Black J, et al. Diagnosis, natural history, and management in vascular Ehlers-Danlos syndrome. Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):40-47. doi: 10.1002/ajmg.c.31553. PMID: 28306228.
| |
|
61. |
Stephens SB, Russo M, Shalhub S, et al. Evaluating perinatal and neonatal outcomes among children with vascular Ehlers-Danlos syndrome. Genet Med. 2022 Oct;24(10):2134-2143. doi: 10.1016/j.gim.2022.07.010. Epub 2022 Aug 20. PMID: 35984436.
| |
